UltraTech Cement (ULTRACEMCO) Q2 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 24/25 earnings summary
8 Jul, 2026Executive summary
Q2 FY25 saw a pre-election and monsoon-driven slowdown, resulting in 68% capacity utilization and 3% domestic volume growth, with consolidated net sales at ₹15,308 crore and PAT at ₹820 crore, both down year-over-year.
EBITDA declined 18% year-over-year to ₹2,718 crore, and PAT fell 36% year-over-year to ₹1,281 crore.
RAK White became a subsidiary in July, with results consolidated.
Urban housing and infrastructure projects are gaining momentum, with several large government projects announced.
Rural demand is expected to improve due to strong monsoons and higher agricultural production.
Financial highlights
Petcoke usage increased to 54% in the fuel mix, reducing fuel cost per Gcal by 8% quarter-over-quarter to INR 1.84.
Cement prices improved from INR 347 in August to INR 354 in October, with Q2 average at INR 348.
Employee costs rose sharply due to annual increments and a one-time bonus, with the underlying increase at 9-10%.
Other expenses were elevated due to maintenance shutdown costs this quarter.
Energy costs declined 14% YoY, while raw material costs increased 1%.
Outlook and guidance
Ongoing capacity expansion is on track, aiming to surpass 200 MTPA by FY27 with recent and pending acquisitions.
Expecting double-digit volume growth in H2, with profitability improvement driven by price recovery and normalization of seasonal costs.
Industry capacity additions projected at 30 million tons annually for this and next fiscal, with UltraTech contributing about half.
Rural, infra, and urban demand expected to drive H2 growth.
Management expects sustainable volume growth of 7-8% in future years, driven by infrastructure and housing demand.
Latest events from UltraTech Cement
- Record Q1 FY27 with 16% sales growth, 17% PAT rise, and strong volume and margin gains.ULTRACEMCO
Q1 26/2720 Jul 2026 - Q2FY26 profit jumped 75% YoY on strong volume growth, cost control, and expansion.ULTRACEMCO
Q2 25/269 Jul 2026 - Q1 FY26 saw 13% revenue and 49% profit growth, with record capacity and major acquisitions.ULTRACEMCO
Q1 25/268 Jul 2026 - Q3FY26 revenue and EBITDA rose sharply on robust demand, expansion, and cost efficiencies.ULTRACEMCO
Q3 25/268 Jul 2026 - Q1 FY25 delivered higher sales, stable profits, and expanded green power amid price softness.ULTRACEMCO
Q1 24/2518 Jun 2026 - Record sales, profit, and capacity in FY26, with higher dividend and strong green power gains.ULTRACEMCO
Q4 25/2628 Apr 2026 - Double-digit growth, capacity expansion, and new ventures drive strong market leadership.ULTRACEMCO
Investor presentation24 Jan 2026 - Leading market share, strong financials, and major expansion drive UltraTech’s growth.ULTRACEMCO
Investor presentation24 Jan 2026 - Q3 FY25 saw 10% volume growth and major acquisitions, but PAT declined year-over-year.ULTRACEMCO
Q3 24/259 Jan 2026